Refine by
Immune Disease Articles & Analysis
90 news found
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with ...
This precise dissociation is pivotal for advancing studies on immune response and related disease mechanisms. Read the application note EPISODE 1: THE HEART EPISODE 2: THE LUNG EPISODE 3: THE LIVER ...
Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. ...
Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. ...
However, some species are known to be a serious infection risk for individuals with comorbidities such as weakened immune systems or lung disease. Of the approximately 180 species of Aspergillus, fewer than 40 of them are known to cause infections in humans according to the Centers for Disease Control and Prevention (CDC). ...
TCR-Seq, short for T Cell Receptor Sequencing, is an instrumental tool that enables scientists and researchers to decode the intricate tapestry of T cell populations within the immune system. This critical information holds immense potential in unraveling immune responses, gaining insights into autoimmune diseases, advancing cancer immunotherapy, ...
However, some species are known to be a serious infection risk for individuals with weakened immune systems or lung disease. Of the approximately 180 species of Aspergillus, fewer than 40 of them are known to cause infections in humans according to the Centers for Disease Control and Prevention (CDC). ...
HLA regions are associated with the greatest number of human diseases in the human genome, and HLA typing is particularly important for assessing immune compatibility between organ donor and recipient pairs. ...
"Our AI platform basically mimics the human immune system using AI," said Ofran. "For this program, we chose the IL-2 pathway, which is well-studied and extensively explored. ...
Vividion will continue its mission to unlock high value, traditionally undruggable target biology with precision therapeutics for cancers and immune disorders. Under Jeffrey Hatfield’s leadership since 2020, Vividion has grown from a small, research startup to a mid-sized successful biotech company with nearly 200 employees. ...
ByBayer AG
Meanwhile, a large number of potential candidate peptides targeting the metabolic, cardiovascular, central and peripheral nervous systems, as well as endocrine, immune, hematological, allergic, and other malignant diseases, are in early-stage research or clinical trials. ...
Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious diseases. Chimeric’s exclusive global license from CWRU covers patent rights, knowhow, and biological materials in relation to therapeutic products for the NKF feeder cell line and CORE-NK manufacturing process in the fields of use, including ...
Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious diseases. “We are excited to continue building on our collaboration with CWRU with the definitive license agreement for the CORE-NK platform,” said Jennifer Chow, CEO and Managing Director of Chimeric. ...
“We look forward to combining our product development expertise with the capabilities of AFRIMS in chikungunya epidemiology and field studies, and of our academic partners in infectious disease modeling and efficacy trial design, to find ways to address chikungunya disease, a public health threat for which no vaccine or treatment ...
Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. However, despite the remarkable impact of FDA-approved biologics based on secreted proteins such as insulin, human growth hormone, and erythropoietin, this class of biologics ...
The trial will use CDM® technology to assess the efficacy of XPro™ compared with placebo on grey matter integrity in patients with mild AD. The role of the immune system and inflammation in Alzheimer’s disease has been broadly known for years but it is becoming increasingly clear that effective management of AD may require anti-inflammatory ...
The company is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis – a global healthcare problem that is more common than heart attack and claims more lives than any cancer. Infectious disease testing (including sepsis) is one of the fastest growing molecular diagnostic segments ...
Further, the Agreement entails clinical development to expand Grafalon’s regulatory approval in China to the prevention of Graft versus Host Disease following allogenic stem cell transplantation (“SCT”), so as to align its approved usages in China with those in Europe and other countries worldwide. Additional objective is to evolve Grafalon’s usages from ...
Cytokine assays can determine the immune function of the body and are important for diagnosis, disease course observation, efficacy determination, and treatment monitoring. ...
“We currently manage high-level BK viremia by reducing immunosuppressive therapy, which can help a patient’s immune system clear the virus, but this approach raises the risk that the immune system will attack and reject the graft. The potential for posoleucel to specifically restore immunity to BKV as an alternative to reducing ...
ByKalaris